Cookies auf der KCI-Website
Wir verwenden Cookies, um Ihnen die Nutzung unserer Website zu erleichtern. Weitere Informationen zu Cookies und deren Verwendung erhalten Sie hier Privacy Policy. Um Ihnen das Navigieren zu erleichtern, empfehlen wir Ihnen, die Cookies zu akzeptieren.
Eingabehilfen | Sitemap | Kontaktieren Sie uns | Service-Hotline 0800/7833524
Deutschland Change Country
Startseite  |  Einsatzgebiete  |  Produkte  |  Klinische Evidenz  |  Fortbildung & Training  |  Für Patienten  |  Kundendienst
Sie sind hier Startseite > Nachrichten & Medien > Acelity Partners with GHD to Expand Access to Advanced Wound Dressing Portfolio in Germany
Drucken

Acelity Partners with GHD to Expand Access to Advanced Wound Dressing Portfolio in Germany

Freigegeben : 10 September 2015

Partnership increases Acelity’s Footprint in German Market

KCI, Leader in Advanced Wound Care Solutions

SAN ANTONIO, September 10, 2015 — Acelity, a global wound care and regenerative medicine company, today announced that it has entered into a strategic commercial partnership with GHD GesundHeits GmbH Deutschland (GHD) to distribute Acelity’s Advanced Wound Dressings portfolio (AWD) known under Systagenix in Germany. The partnership with GHD, the largest provider of homecare services in Germany, offers Acelity access to GHD’s breadth of customers in both acute and post-acute care settings.

“This important partnership positions Acelity for growth in the German market by strengthening our distribution network and creating multiple access points to customers,” said Laura Piccinini, president, Acelity Developed Markets. “The size and reach of GHD enables increased access to prescribers, wound care and nursing specialists in the field, making Acelity dressings available to thousands of additional patients throughout Germany.”

GHD has a proven track record of partnering with manufacturers to increase access-to-care by offering integrated, high-quality healthcare services for customers and patients. Under the terms of the agreement, GHD will be exclusively responsible for the distribution of all Acelity AWD products, including TIELLE®, ADAPTIC TOUCH®, SILVERCEL® and PROMOGRAN®/PROMOGRAN PRISMA® in Germany.

“At GHD we pride ourselves in developing exclusive partnerships with the best manufacturers in our target segments, and Acelity’s industry-leading reputation makes this arrangement a smart, natural fit,” said Andreas Rudolph – Shareholder and Management Board Chairman of GHD. “Our new partnership with Acelity will give our customers access to a full range of best-in-class wound care products that are competitively-priced.”

 

About Acelity

Acelity L.P. Inc. and its subsidiaries are a global advanced wound care and regenerative medicine company created by uniting the strengths of three companies, Kinetic Concepts, Inc., LifeCell Corporation and Systagenix Wound Management, Limited. Available in more than 75 countries, the innovative and complementary Acelity product portfolio delivers value through solutions that speed healing and lead the industry in quality, safety and customer experience. Headquartered in San Antonio, Texas, Acelity employs more than 5,700 people around the world. For more information please see www.acelity.com

 

About GHD GesundHeits GmbH Deutschland

The GHD GesundHeits GmbH Deutschland is Germany's largest provider of homecare services, offering integrated, high-quality care for customers and patients. GHD GesundHeits GmbH Deutschland forms the Group's strategic and administrative umbrella. This is where all centralized and decentralized sections of the Group are coordinated, the main focus being on ongoing expansion and extension of our range of healthcare services, while at the same time maintaining the most stringent quality standards. The expertise of GHD is based on the five pillars of Production, Logistics, Homecare/Service and Pharmaceuticals Service and Distribution. For more information please see www.gesundheitsgmbh.de/en

 

For more information, contact:


Kathryn Skeen
Corporate Communications
Phone: +1-210-882-2067
Email: kathryn.skeen@acelity.com

Caleb Moore
Investor Relations
Email: caleb.moore@acelity.com



  • Share on Facebook.com
  • Share on Twitter
  • Besuchen Sie unsere YourTube Seite

Wichtige Mitteilung für Patienten

Rechtliches | Datenschutzrichtlinien | Kontaktieren Sie uns | Impressum


© 1998 – 2013 KCI Licensing, Inc. Alle Rechte vorbehalten.    DSL# 09-03-193.DE

Die Informationen auf dieser Website wurden ausschließlich zur Nutzung in Deutschland / KCI Medizinprodukte GmbH bereitgestellt. Diese Website enthält Informationen über Produkte, die möglicherweise nicht in allen Ländern verfügbar sind. Es ist außerdem möglich, dass sie von den zuständigen Behörden in bestimmten Ländern noch nicht oder nicht für bestimmte Indikationen zugelassen sind.